Single-phase-to-ground fault protection based on zero-sequence current ratio coefficient for low-resistance grounding distribution network

Definite-time zero-sequence over-current protection is presently used in systems whose neutral point is grounded by a low resistance(low-resistance grounding systems).These systems frequently malfunction owing to their high settings of the action value when a high-impedance grounding fault occurs.In this study,the relationship between the zero-sequence currents of each feeder and the neutral branch was analyzed.Then,a grounding protection method was proposed on the basis of the zero-sequence current ratio coefficient.It is defined as the ratio of the zero-sequence current of the feeder to that of the neutral branch.Nonetheless,both zero-sequence voltage and zero-sequence current are affected by the transition resistance,The influence of transition resistance can be eliminated by calculating this coefficient.Therefore,a method based on the zero-sequence current ratio coefficient was proposed considering the significant difference between the faulty feeder and healthy feeder.Furthermore,unbalanced current can be prevented by setting the starting current.PSCAD simulation results reveal that the proposed method shows high reliability and sensitivity when a high-resistance grounding fault occurs.

Membrane-targeting amphiphilic AIE photosensitizer for broad-spectrum bacteria imaging and photodynamic killing of bacteria

An amphiphilic AIE photosensitizer has been successfully developed,which allows for easily inserting into the bacterial membranes.Binding experiments with phospholipid preliminary demonstrates its membrane specificity.As expected,it is proved to possess a broad-spectrum bacterial staining performance and photodynamic antibacterial activity toward S.aureus and E.coli.

Programmable endonuclease combined with isothermal polymerase amplification to selectively enrich for rare mutant allele fractions

Liquid biopsy is a highly promising method for non-invasive detection of tumor-associated nucleic acid fragments in body fluids but is challenged by the low abundance of nucleic acids of clinical interest and their sequence homology with the vast background of nucleic acids from healthy cells.Recently,programmable endonucleases such as clustered regularly interspaced short palindromic repeats(CRISPR)associated protein(Cas)and prokaryotic Argonautes have been successfully used to remove background nucleic acids and enrich mutant allele fractions,enabling their detection with deep next generation sequencing(NGS).However,the enrichment level achievable with these assays is limited by futile binding events and off-target cleavage.To overcome these shortcomings,we conceived a new assay(Programmable Enzyme-Assisted Selective Exponential Amplification,PASEA)that combines the cleavage of wild type alleles with concurrent polymerase amplification.While PASEA increases the numbers of both wild type and mutant alleles,the numbers of mutant alleles increase at much greater rates,allowing PASEA to achieve an unprecedented level of selective enrichment of targeted alleles.By combining CRISPR-Cas9 based cleavage with recombinase polymerase amplification,we converted samples with0.01%somatic mutant allele fractions(MAFs)to products with 70%MAFs in a single step within 20 min,enabling inexpensive,rapid genotyping with such as Sanger sequencers.Furthermore,PASEA's extraordinary efficiency facilitates sensitive real-time detection of somatic mutant alleles at the point of care with custom designed Exo-RPA probes.Real-time PASEA'performance was proved equivalent to clinical amplification refractory mutation system(ARMS)-PCR and NGS when testing over hundred cancer patients'samples.This strategy has the potential to reduce the cost and time of cancer screening and genotyping,and to enable targeted therapies in resource-limited settings.